Courses

The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

In this module, Rowena Schwartz PharmD, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide current data for treating patients with biosimilars in the era of the COVID-19 pandemic. The expert faculty will highlight the evolving impact of COVID-19 on healthcare expenditure, including availability of services and financial burdens. Therapeutic considerations amidst the pandemic will be ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

In this module, Jonathan Kay, MD, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Francis A. Farraye, MD, MSc, will review current clinical trial data, including registry data, of biosimilar therapeutics in patients with rheumatological disorders. The expert faculty will analyze recent studies, debating the clinical implications of each. Terms such as biosimilarity, changing and switching will ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

In this module, Francis A. Farraye, MD, MSc, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Jonathan Kay, MD, will analyze current clinical trial of data of biosimilar agents, particularly in gastroenterological disorders. Efficacy and immunogenicity in both induction and switching studies will be reviewed, and clinical relevance debated. The expert faculty will also relay societal guidelines ...
View Course
Patient Education and Shared Decision-Making Specific to Biosimilar Therapeutics: The Why and The How

Patient Education and Shared Decision-Making Specific to Biosimilar Therapeutics: The Why and The How

In this module, Amy Goodrich, RN, BSN, MSN, CRNP-AC, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will highlight best practices for shared decision making as well as strategies for administering comprehensive patient education to promote adherence to biosimilar agents. The expert faculty will review methods to minimize the ‘nocebo’ effect and improve outcomes in patients with inflammatory ...
View Course
Biosimilars 101: The Science, Approval Process, and Extrapolation of Clinical Data and Indications

Biosimilars 101: The Science, Approval Process, and Extrapolation of Clinical Data and Indications

In this module, Ali McBride, PharmD, MS, BCPS, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide background information regarding the science and approval process of biosimilar agents in inflammatory conditions. Topics such as immunogenicity and the extrapolation framework will also be reviewed in a discussion-based format. At the conclusion of this 30-minute interview segment, learners ...
View Course
Advances in the Management of Gout

Advances in the Management of Gout

This CME/CNE program is derived from content presented at the Congress of Clinical Rheumatology 2019. The expert faculty will provide an overview of current and emerging therapies for the treatment of gout. This includes an analysis of lifestyle changes and pharmacological interventions as it relates to improving patient outcomes. The faculty will also discuss pathophysiology, prevention, accurate diagnosis, and imaging ...
View Course
Applying Novel Approaches in Psoriatic Arthritis to More Effectively Treat Patients

Applying Novel Approaches in Psoriatic Arthritis to More Effectively Treat Patients

This CME/CNE program is derived from content presented at the Congress of Clinical Rheumatology 2019. The expert faculty will provide clinicians with an overview of the immunopathogenesis of psoriatic arthritis (PsA). The faculty will analyze the most recent data for the treatment of PsA, highlighting the clinical relevance of both current and emerging therapeutic agents. Managing patients with psoriatic arthritis, ...
View Course
The Advances in Monoclonal Antibody Therapeutics to Improve Outcomes in Patients With Psoriatic Arthritis and Ankylosing Spondylitis

The Advances in Monoclonal Antibody Therapeutics to Improve Outcomes in Patients With Psoriatic Arthritis and Ankylosing Spondylitis

This CME/CNE activity is derived from content presented at the International Society for Musculoskeletal Imaging in Rheumatology (ISEMIR) Annual Meeting in Dallas, Texas. The expert faculty, Dr. Alvin F. Wells, will review the characteristics of both psoriatic arthritis (PsA) and ankylosing spondylitis (AS) to ensure accurate detection and early diagnosis. Recent guidelines for the treatment and management of PsA and ...
View Course
Utilizing Individualized Treatment Plans to Reduce Disease Activity and Pain Levels in Patients With Rheumatoid Arthritis

Utilizing Individualized Treatment Plans to Reduce Disease Activity and Pain Levels in Patients With Rheumatoid Arthritis

This CME program was derived from content presented at the Clinical Congress of Rheumatology 2018 annual meeting in Destin, Florida. The expert faculty, Dr. Grace C. Wright, will discuss the state of disease of rheumatoid arthritis (RA) in an ever evolving treatment landscape. Recent clinical trial data for approved biologic therapies will be analyzed along with data for emerging JAK1/JAK2 ...
View Course
Updates on Therapeutic Strategies to Optimize Clinical Outcomes in Psoriatic Arthritis

Updates on Therapeutic Strategies to Optimize Clinical Outcomes in Psoriatic Arthritis

This CME program was derived from content presented at the Clinical Congress of Rheumatology 2018 annual meeting in Destin, Florida. The expert faculty, Drs. Alan L. Epstein and Anthony M. Turkiewicz, will review the pathogenesis of disease as well as joint symptoms for patients with active psoriatic arthritis (PsA). Controversies in the treatment and management of PsA along with rheumatoid ...
View Course